Roanoke Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $134K | Hold |
40,360
| – | – | 0.05% | 88 |
|
|
2024
Q4 | $299K | Hold |
40,360
| – | – | 0.1% | 74 |
|
|
2024
Q3 | $379K | Hold |
40,360
| – | – | 0.12% | 75 |
|
|
2024
Q2 | $324K | Hold |
40,360
| – | – | 0.11% | 75 |
|
|
2024
Q1 | $598K | Sell |
40,360
-780
| -2% | -$11.6K | 0.2% | 62 |
|
|
2023
Q4 | $334K | Buy |
41,140
+5,840
| +17% | +$47.4K | 0.12% | 78 |
|
|
2023
Q3 | $161K | Hold |
35,300
| – | – | 0.07% | 93 |
|
|
2023
Q2 | $249K | Buy |
35,300
+22,500
| +176% | +$159K | 0.1% | 93 |
|
|
2023
Q1 | $78K | Buy |
+12,800
| New | +$78K | 0.03% | 100 |
|